La terapia con células madre muestra eficacia en el tratamiento de la COVID-19, encuentra estudio
Researchers in China administered COVID-19 patients with a mesenchymal stem cell therapy that demonstrated success at treating the condition.
Blue stem cells
A group of researchers has used a stem cell treatment on a patient in Beijing, China to effectively boost the immune system to fight the COVID-19 coronavirus.
“A lot of people are trying find the answers,” said scientist that led the research
He said that early findings are promising and the international effort to test this treatment continues as a long-term study with more patients in China.
“Our study showed that intravenous infusion of clinical-grade human mesenchymal stem cells is a safe and efficient approach for treating patients with COVID-19 pneumonia, including in elderly patients displaying severe pneumonia," .
The stem cells were injected intravenously into the bloodstream of seven patients in YouAn Hospital in Beijing who were severely ill, while three patients were injected with a placebo.
The seven patients who received stem cells were successfully treated and discharged from the hospital within 14 días, report the researchers. Of the patients who received the placebo, one died, one became severe and the third had Acute Respiratory Distress Syndrome (SDRA).
“No specific drugs or vaccines are available to cure the patients with COVID-19 infection,” write the authors of the study. “Hence, there is a large unmet need for a safe and effective treatment for COVID-19 infected patients, especially the severe cases.”
The findings are published in Aging and Disease.
Interesado en saber si los programas clínicos actuales, desarrollos de investigacion, o enfoques terapéuticos emergentes pueden ser relevantes para su situación?
Información educativa y de investigación únicamente.. Las decisiones médicas individuales deben tomarse en consulta con profesionales sanitarios cualificados..
